Delivery Order SPE2DB22D2206-SPE2DB25FFE93
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$69K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $3,741.63 and is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award, with a total ceiling value of $19,821.41, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific pharmaceutical product, RINVOQ ER 15 MG TABLET UU 30S, with a completion date of February 1, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RINVOQ ER 15 MG Tablet prescriptions. The contract has a ceiling value of $12,086.55 and an ultimate completion date of May 9, 2024. It is a Firm Fixed Price delivery order contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $29,786.60 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, valued at $6,649.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 9, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is a Delivery Order for $96,329.87 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a prescription medication, RINVOQ ER 45 MG TABLET, with a performance period ending on September 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $24,186.17 and has a period of performance through November 2023. It provides for the delivery of the drug RINVOQ ER 15 MG TABLET UU 30S, which is used to treat certain medical conditions. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
The federal contract award SPE2DX15D3001|SPE2DX24F4SS5 was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S to the U.S. government. The $11,126.22 firm fixed price delivery order contract has a completion date of June 27, 2024 and was awarded on June 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD)....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of RINVOQ ER 15 MG TABLET medication, with a firm fixed price of $6,015.42 and a completion date of February 27, 2024. The contract does not have a set-aside designation and is a delivery order under a larger indefinite delivery contract (IDC) awarded solely to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RINVOQ ER 30 MG TABLET UU 30S. The award, valued at $13,434.13, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of a diverse range of pharmaceutical products and medical...